RE:Keep reporting to Stockhouse those off topic posts!Dr Mandel has one month left as interim CEO.
As far as investors are aware the only attempt to conform to item #3 of the terms of Agreement is to place a CEO job listing on the company website for the first 2 weeks of December. application closing date 15 Dec. 2018.
1) Were other methods used in attempting to acquire an external CEO?
We don't know.
2) Is the OSC prepared to extend Dr Mandel's time as interim CEO?
We don't know.
3) Has the company complied with the other terms of the OSC Agreement?
We don't know.
I have emailed the company more than once listing the terms of Agreement and asking for confirmation regarding the companiy's compliance.
No answer.
It seems any query that does not pertain to the science but asks for process on the management end is met with a WALL of silence.